CD40 and familial pancreatic carcinoma: A previous assessment of NSCLC tumor cells expressing CD40 had cited a 51.9% (n = 129) positivity rate, while a previous pancreatic cancer assessment had reported a 69.2% (n = 26) positivity rate [9, 11].